CellPro regulatory update

The Bothell, Wash., company filed an amended PMA with the FDA. The amendment provides data in answer to questions raised by the FDA in December, when the agency sent the company a "not approvable" letter for its Ceprate SC stem cell concentration system (see BioCentury Jan. 3). ...